Header cover image

Taiwanese (TAIEX) Healthcare Services Industry Analysis

UpdatedMay 15, 2024
DataAggregated Company Financials
Companies11
  • 7D0.2%
  • 3M-3.7%
  • 1Y-22.3%
  • YTDn/a

In the last week, the Healthcare Services industry is flat overall, with Sofiva GenomicsLtd standing out by going down 8.4%. Unfortunately though, the industry is down 22% over the past 12 months.

Industry Valuation and Performance

Has the Taiwanese Healthcare Services Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Wed, 15 May 2024NT$40.4bNT$14.4bNT$1.3b26.4x30.9x2.8x
Fri, 12 Apr 2024NT$41.0bNT$14.4bNT$1.3b26.9x32.2x2.9x
Sun, 10 Mar 2024NT$42.3bNT$14.0bNT$1.2b24.6x34.2x3x
Tue, 06 Feb 2024NT$41.7bNT$14.1bNT$1.2b26.3x33.7x3x
Thu, 04 Jan 2024NT$41.8bNT$14.1bNT$1.2b24.2x33.8x3x
Sat, 02 Dec 2023NT$43.1bNT$14.1bNT$1.2b24.4x34.9x3.1x
Mon, 30 Oct 2023NT$44.3bNT$13.9bNT$1.3b27.2x33.9x3.2x
Wed, 27 Sep 2023NT$47.6bNT$13.9bNT$1.3b27.9x36.4x3.4x
Fri, 25 Aug 2023NT$47.6bNT$13.8bNT$1.3b28.3x36.5x3.4x
Sun, 23 Jul 2023NT$50.7bNT$14.0bNT$1.4b25.1x37.4x3.6x
Tue, 20 Jun 2023NT$51.5bNT$14.0bNT$1.3b26.4x38.5x3.7x
Thu, 18 May 2023NT$49.6bNT$13.7bNT$1.5b21.2x33.5x3.6x
Sat, 15 Apr 2023NT$48.1bNT$13.9bNT$1.5b19x31.7x3.5x
Mon, 13 Mar 2023NT$41.7bNT$13.8bNT$1.7b20.7x24.7x3x
Wed, 08 Feb 2023NT$42.9bNT$13.8bNT$1.7b21x25.4x3.1x
Fri, 06 Jan 2023NT$40.1bNT$13.8bNT$1.7b18.8x23.8x2.9x
Sun, 04 Dec 2022NT$38.9bNT$13.8bNT$1.7b19.4x23.1x2.8x
Tue, 01 Nov 2022NT$35.1bNT$13.4bNT$1.6b16.8x22.6x2.6x
Thu, 29 Sep 2022NT$38.4bNT$13.4bNT$1.6b18.8x24.7x2.9x
Sat, 27 Aug 2022NT$44.3bNT$13.4bNT$1.6b19.3x28.5x3.3x
Mon, 25 Jul 2022NT$39.9bNT$12.6bNT$1.3b31.3x29.9x3.2x
Wed, 22 Jun 2022NT$36.7bNT$12.6bNT$1.3b31.6x27.5x2.9x
Fri, 20 May 2022NT$34.0bNT$12.4bNT$1.3b28.5x26.7x2.7x
Sun, 17 Apr 2022NT$36.0bNT$12.1bNT$1.2b27.6x29.1x3x
Tue, 15 Mar 2022NT$39.3bNT$11.6bNT$1.1b29.7x36.6x3.4x
Thu, 10 Feb 2022NT$32.7bNT$11.6bNT$1.1b30.3x30.5x2.8x
Sat, 08 Jan 2022NT$32.1bNT$11.6bNT$1.1b19.4x29.9x2.8x
Mon, 06 Dec 2021NT$32.6bNT$11.6bNT$1.1b18.8x30.4x2.8x
Wed, 03 Nov 2021NT$36.3bNT$11.8bNT$1.2b15.6x30.8x3.1x
Fri, 01 Oct 2021NT$35.7bNT$11.8bNT$1.2b22.6x30.3x3x
Sun, 29 Aug 2021NT$36.1bNT$11.8bNT$1.2b23.4x30.6x3.1x
Mon, 05 Jul 2021NT$39.3bNT$11.8bNT$1.2b23.3x33.3x3.3x
Price to Earnings Ratio

29.1x


Total Market Cap: NT$36.0bTotal Earnings: NT$1.2bTotal Revenue: NT$11.6bTotal Market Cap vs Earnings and Revenue0%0%0%
Taiwanese Healthcare Services Industry Price to Earnings3Y Average 30.7x202220232024
Current Industry PE
  • Investors are relatively neutral on the Taiwanese Healthcare Services industry at the moment, indicating that they anticipate long term growth rates to remain steady.
  • The industry is trading close to its 3-year average PE ratio of 30.7x.
  • The industry is trading close to its 3-year average PS ratio of 3.1x.
Past Earnings Growth
  • The earnings for companies in the Healthcare Services industry have remained mostly flat over the last three years.
  • Meanwhile revenues for these companies have grown 7.3% per year.
  • This means that although more sales are being generated, either the cost of doing business or the level of investment back into businesses has increased and as a result, profits have held steady.

Industry Comparison

How does Taiwanese Healthcare Services compare with similar industries?

TW Market1.33%
Healthcare0.63%
Healthcare Services-0.23%
Healthcare Services0.15%
Managed Healthcare0%
Healthcare Facilities-0.48%
Healthcare Distributors-0.58%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
3218 Universal Vision BiotechnologyNT$257.501.8%
+NT$381.3m
-31.9%PE20.1x
6637 Medical ImagingNT$109.008.5%
+NT$182.3m
88.3%PE19.3x
6879 TCI GENENT$79.001.3%
+NT$26.5m
-36.0%PE179.1x
8403 ShareHope MedicineNT$32.300.6%
+NT$25.2m
-7.6%PE32.7x
1784 BIONETNT$65.900.5%
+NT$14.2m
-0.6%PE39.8x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

3218

NT$257.50

Universal Vision Biotechnology

7D

1.8%

1Y

-31.9%

6615

NT$43.30

Sofiva GenomicsLtd

7D

-9.0%

1Y

1.9%

8403

NT$32.30

ShareHope Medicine

7D

0.6%

1Y

-7.6%

4139

NT$29.70

Ma Kuang Healthcare Holding

7D

0.7%

1Y

-20.6%

1784

NT$65.90

BIONET

7D

0.5%

1Y

-0.6%

6665

NT$25.50

Healthconn

7D

-6.6%

1Y

-34.5%

6744

NT$23.00

Feng Chi Biotech

7D

0.7%

1Y

-17.7%

6637

NT$109.00

Medical Imaging

7D

8.5%

1Y

88.3%

6518

NT$24.20

Concord Medical

7D

-2.0%

1Y

-16.1%

4724

NT$35.35

Meribank Biotech

7D

-0.1%

1Y

n/a

6879

NT$79.00

TCI GENE

7D

1.3%

1Y

-36.0%